The structural heterogeneity of α-synuclein, amyloid β, and tau aggregates could form the molecular basis for the broad spectrum of phenotypes seen in synucleinopathies, Alzheimer’s disease, and other tauopathies. The gene discussed is MAPT; the disease is synucleinopathy.